Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 83/100

Axonics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 02:00PM GMT
Release Date Price: $61.29 (+5.44%)
David Kenneth Rescott
Truist Securities, Inc., Research Division - Former Associate

Well, thank you guys, for coming. Really delighted today to be joined with the Axonics team. We have Co-Founder and CEO, Ray Cohen, and we have incoming CFO, Kari Keese. Before I get started, just some research disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So getting started, Ray, curious how you're spending your time at the moment. It's been 10 years since co-founding Axonics. So keen to hear how the split of your time has shifted?

Questions & Answers

Raymond W. Cohen
Axonics, Inc. - CEO & Director

Now it's an interesting question. So I think the focus clearly is always on driving revenue. We've gone through the product development phase, the clinical studies and all that other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot